Skip to main content
. 2021 Jul 15;22:264. doi: 10.1186/s12882-021-02449-0

Table 2.

Adjusted models: Cox model of mortality and Competing risks Regression models of ESKD and Death

Medication group Cox model of Mortality
HR (95% CI)*
(N = 25,455, death events = 5562)
P-value Competing Risks ESKD with death as competing risk
SHR (95% CI)*
(N = 25,455, ESKD events = 452, death events = 5362)
P-value Competing Risks Death with ESKD as competing risk
SHR (95% CI)*
(N = 25,455, ESKD events = 452, death events = 5362)
P-value
PPI vs. none 0.97 (0.91, 1.03) 0.29 0.93 (0.75, 1.15) 0.49 0.96 (0.90, 1.02) 0.15
H2 vs. none 0.99 (0.86, 1.15) 0.90 1.07 (0.67, 1.73) 0.77 1.01 (0.87, 1.17) 0.95
PPI vs. H2 0.98 (0.84, 1.13) 0.77 0.87 (0.53, 1.42) 0.57 0.95 (0.82, 1.11) 0.53

*Adjusted for age, race, sex, eGFR, BMI group, hemoglobin, potassium, CO2, diabetes, hypertension, CVD, PVD,CAD, CHF, malignancy, ACE/ARB, beta blockers, smoking and insurance

All adjusted models used 5 datasets created with multiple imputation and MI analyze to obtain the HR or SHR